Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2019 | Q2 | -- | -- | -- | -$208.17 | -- |
| 03/31/2019 | Q1 | -- | -- | -- | -$104.09 | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -- | -$5,107.44 | -- |
| 06/30/2018 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -- | -$7,794.30 | -- |
| 12/31/2017 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -- | -$6,395.04 | -- |
| 06/30/2017 | Q2 | -- | -- | -- | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -- | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -- | -- | -- |
Biodexa Pharmaceuticals Plc reported -- worth of top line sales in its most recent quarter.
Biodexa Pharmaceuticals Plc announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
Biodexa Pharmaceuticals Plc reported -- that represents -- per share over the last quarter.
Biodexa Pharmaceuticals Plc's earnings are forecast to decrease from -$148.23 per share to -$0.63 per share next year representing a decrease of -99.64%.
Currently, Biodexa Pharmaceuticals Plc has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 13, 2026.
Signup to receive the latest stock alerts
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Since January 28th, software stocks in the United States have…
Over the last five days, shares of Instagram and Facebook…
Market Cap: $4.5T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 34x
Market Cap: $3.7T
P/E Ratio: 28x
American Public Education, Inc. [APEI] is up 26.24% over the past day.
Papa John's International, Inc. [PZZA] is down 5.25% over the past day.
Nebius Group NV [NBIS] is up 0.87% over the past day.